Defense Tech16 MAR 2026
UAE Firm to Invest $200M in Defence Technology Development in Nigeria
A landmark cross-border deployment establishing a sovereign-grade UAS and EW manufacturing footprint across West Africa.
Read briefElmirate Capital deploys patient, conviction-led capital across Defense, Aerospace, Quantum and frontier technologies — backing the companies, scientists and sovereigns who will define the next half-century.
We are not an ROI fund. We are a relevance fund. We measure success in strategic capability built, supply chains de-risked, and economies materially advanced. From our base on Sheikh Zayed Road, we move where the future is being made.
Drawn from sovereign LPs, family offices and strategic corporates across the Gulf, Europe and Asia. Deployed in instruments from seed equity to growth, control buyouts, IPO-bridge and structured project finance.
Autonomous platforms, ISR, electronic warfare, secure comms, force-multiplying robotics. We back the prime contractors of 2040.
Launch, satellite constellations, in-orbit services, lunar logistics, hypersonic vehicles. The orbital economy is sovereign infrastructure.
Quantum hardware, post-quantum cryptography, neuromorphic chips, photonic compute. The substrate of sovereign intelligence.
SMR & advanced nuclear, fusion, geothermal, grid-scale storage, critical minerals processing. Energy is sovereignty.
Pandemic-grade diagnostics, synthetic biology, longevity therapeutics, neurotechnology. Biology is the next computational frontier.
Foundation models, secure inference, offensive & defensive cyber, autonomous decision systems. Compute is the new diplomacy.
The next two decades will be defined by sovereign technological independence. Countries that own their compute, their orbital infrastructure, their energy stack, and their defense industrial base will set the terms of the global order. Those that do not, will not.
Elmirate Capital exists to back the founders, fund managers and state-aligned platforms building this independence. We deploy patient capital with operational depth — and we measure ourselves not in IRR alone, but in strategic capability created.
Our LPs are sovereigns and dynastic capital pools who understand that returns and relevance are not in tension. They compound together.
Anchor capital and seed-mandates for emerging GP managers across frontier markets. We back the next generation of regional platform builders.
Operating-partner platform. Embedded advisory across go-to-market, regulatory, sovereign relationships and growth — for funds and founders.
Direct venture and growth-stage equity. Conviction checks into deep-tech founders building on the frontier — from seed through pre-IPO.
M&A, cross-border consolidation and IPO-readiness. The exit and inflection arm — for portfolio and external mandates alike.
A landmark cross-border deployment establishing a sovereign-grade UAS and EW manufacturing footprint across West Africa.
Read briefWhy post-quantum cryptography is now a national-security mandate, and how the Gulf can lead — not follow — the transition.
Read briefOur analysis of laser, microwave and particle-beam programs across the region — and where private capital fits.
Read briefWe hold one investment committee per month. We respond to every credible inbound within 48 hours. Bring the conviction; we bring the capital, the relationships, and the operational muscle.
Engage ElmirateElmirate Capital was founded on a contrarian premise: that the next generation of strategic technologies will not be built by the highest IRR seeker. They will be built by the most patient, most embedded, most sovereign-aligned capital partner in the room.
For four decades, private equity optimized for one number: internal rate of return. That regime built useful firms — but it also produced a generation of capital that flees the moment a thesis takes longer than the fund life to mature.
Defense systems take fifteen years. Quantum hardware takes twenty. A sovereign launch capability takes a generation. None of these timelines fit a 7+2 fund. All of them fit Elmirate.
We structure our capital — through permanent vehicles, sovereign LP partnerships, and patient family-office allocations — to outlast the technology cycle, not chase it.
The best frontier deals are non-consensus by definition. We back theses that the public markets cannot yet price and that conventional GPs cannot underwrite.
We invest in what nations need to control. Compute, energy, defense, biology, orbit. These are not consumer markets — they are sovereign infrastructure.
Our partners have built and sold companies, run defense programs, regulated markets, raised sovereign funds. We sit on the same side of the table as our founders.
Our capital is patient on horizon. Our operating tempo is not. We move fast inside the deal, slow on the exit clock.
We back companies that should one day list on exchanges, anchor sovereign funds, and become national champions — not flip in three years to a strategic.
Every portfolio company has at least three jurisdictions in its DNA. Capability is global; we build companies designed for that reality from day one.
The Elmirate partnership combines roughly 25 years of cybersecurity operating experience, sovereign capital structuring, defense procurement, capital markets and frontier-technology investing. We are deliberately small. Our edge is judgement, not headcount.
Our sectoral focus is narrow by design. We invest only where capability is hard to build, where consequence is high, and where private capital can meaningfully accelerate sovereign outcomes.
The defense industrial base is being rebuilt in front of us. Drone swarms, autonomous ground systems, electronic warfare, secure tactical comms, counter-UAS, ISR, and the entire kill-chain are being rewritten by software-native primes that did not exist a decade ago.
We back the prime contractors of 2040 — from seed-stage robotics to growth-stage offset platforms — with capital and the sovereign relationships to win procurement.
Orbit is no longer a science program. It is sovereign infrastructure — for communications, navigation, surveillance, and increasingly, kinetic deterrence.
We back launch providers, satellite operators, in-orbit service platforms and the broader cislunar economy. Our LP base includes nations actively building national space programs — and that is a moat.
The compute substrate of the next century is being chosen now. Superconducting and trapped-ion qubits, photonic processors, neuromorphic chips, post-quantum cryptography — each carries enormous geopolitical weight.
We invest across the stack: from hardware fabs to algorithm developers to PQC migration platforms. The first nations to operationalize cryptographically-relevant quantum compute will rewrite the rules of intelligence.
Energy is sovereignty. And critical-mineral dependency is the new oil dependency — only with sharper edges and tighter chokepoints.
We deploy capital across SMRs, fusion pilots, geothermal, grid storage and the entire critical-minerals processing stack. We particularly favor projects that materially reduce a partner nation's strategic dependencies.
Biology is becoming a computational discipline. The same tools that compress a vaccine timeline can compress an attack timeline. The same therapeutics that slow ageing can rewrite labour-force economics.
We invest in pandemic-grade diagnostics, synthetic biology platforms, longevity therapeutics, and neurotechnology. Our perspective is unflinching: this is dual-use space, and serious capital must steward it.
Compute is the new diplomacy. Sovereign foundation-model capability, secure inference infrastructure, and elite offensive & defensive cyber are now national-security primitives — not enterprise IT line items.
Our partnership brings 25 years of cybersecurity operating depth to this sector. We back the platforms that nations will, in time, classify.
CHAPTER · III
Most fund families sell four products. We operate four desks of a single house — Capital Nexus, StratEdge, AscendX, and Elmirate Elevate — each with its own mandate, instrument set and partnership, but underwritten by one balance sheet, one Investment Committee, and one thesis: that sovereign-frontier capability compounds where short-cycle capital cannot reach.
The platform beneath platforms.
Capital Nexus is our GP-seeding and anchor-LP arm. We capitalise the next generation of frontier-aligned investment managers — the ones with the right thesis, the wrong reference checks, and no existing institutional cap table — and we stand at their final close before institutional consensus arrives.
This is not fund-of-funds. We seed funds, we acquire stakes in management companies, and we provide the working capital that lets emerging GPs stand up real institutional infrastructure. In return, we shape thesis, LP base, and portfolio.
Speak with the Capital Nexus deskCapital that operates.
Frontier-technology companies do not fail on technology. They fail on the institutional scaffolding around the technology — government affairs, export controls, capital-markets posture, the ability to land a sovereign customer and survive the procurement cycle that follows.
StratEdge places senior operators inside our portfolio companies — ex-government, ex-defense-prime, ex-public-company-CFO — and stays until the function is institutionalised. The cost sits on our balance sheet. The benefit sits on the company's.
Engage StratEdgeDirect conviction. Concentrated capital.
AscendX is our direct venture and growth-equity desk. Stage-agnostic by design, sector-disciplined by mandate — defense, aerospace, quantum, advanced energy, dual-use compute, and the frontier biology adjacent to all of it.
We do not run an index. We do not run a programme. We run a portfolio of companies whose absence, if they failed, would degrade the strategic capacity of the nations that depend on them. That filter is severe — and it is the filter.
Bring a company to AscendXFrom private conviction to public mandate.
A liquidity event is not an exit — it is a transition of stewardship. Done badly, it forfeits a decade of mission alignment in eight weeks of a roadshow. Done well, it locks in the strategic posture for the next decade.
Elevate runs the full readiness arc: financial reporting maturity, governance reconstruction, regulatory-jurisdiction selection, banker syndicate design, narrative architecture for institutional buyers. Where the better answer is a strategic transaction, we run that process instead.
Discuss a transition with Elevate| I Capital Nexus |
II StratEdge |
III AscendX |
IV Elevate |
|
|---|---|---|---|---|
| What it is | Anchor LP & GP seed | Embedded advisory | Direct equity | Liquidity architect |
| Counterparty | Emerging GPs | Portfolio operators | Founders | Bankers · acquirers |
| Stage | Fund I & II | Series A → pre-IPO | Series B → pre-IPO | Pre-listing · exit |
| Cheque or weight | $25M – $150M | Operator-time | $15M – $150M | Transaction-fee |
| Time horizon | 10+ years | 2 – 6 quarters | 6 – 8 years | 12 – 24 months |
| Decision body | IC · unanimous | Partner-led | IC · unanimous | IC + bankers |
The four desks are not silos — they are stations on a single arc. A founder may meet StratEdge at concept stage, raise from AscendX at Series B, consolidate competitors with Elevate at growth stage, and route the listing through banking syndicates anchored by Capital Nexus LPs. The spine is intentional.
Pre-financing engagement. Thesis pressure-testing, regulatory mapping, customer pre-validation.
Conviction equity led by AscendX. Capital Nexus seeds adjacent fund managers in the same thesis.
Cross-border M&A and structured growth financings to assemble institutional scale.
Listing or strategic transaction. LPs anchor the float. Stewardship transition, not exit.
Our investment process is deliberately slow at the front and fast at the back. We spend most of our time on thesis development and origination. Once we are in, we move with operator urgency.
We start with the question, not the company. Our partners spend roughly 60% of their time on primary research — sovereign briefings, defense procurement officers, scientists, regulators, operators. We write a thesis only after thirty conversations.
We rarely respond to inbound decks. The companies we back are usually known to us 12–24 months before financing. First conversations are about the science and the operator, not the term sheet.
Technical, regulatory, geopolitical and operational diligence — run in parallel by our internal team and a vetted bench of subject-matter experts. We structure to align with sovereign procurement realities, not VC playbooks.
A single, unanimous committee. We do not rubber-stamp partner conviction; every memo is interrogated by partners outside the deal lead. If we say no, we say it within two weeks.
Day-one onboarding into the StratEdge operating bench. Quarterly board cadence. Sovereign relationship handoffs where useful. We are co-builders, not observers.
M&A, IPO, secondary, or — frequently — continued private compounding inside permanent vehicles. We never force a clock. The right exit is the one that maximizes long-term sovereign relevance.
A clear list of things we have decided, in advance, never to fund — regardless of return profile.
Our private equity practice is built around a single insight: the most consequential companies of the next two decades will not be born inside conventional fund timelines. They require permanent-style capital, sovereign-grade relationships, and operator depth. We provide all three.
Permanent and semi-permanent capital structures, sovereign LP commitments, and family-office allocations. Designed to outlast technology cycles, not chase them.
Where appropriate we use evergreen vehicles. The fund life does not force the exit.
Our LP base includes seven sovereign and semi-sovereign capital pools. That access is portfolio-shaping.
Every IC memo is co-authored with at least one partner who has built or run a company in the relevant sector.
We meet companies 12–24 months before they raise. By the time the deck circulates, we have already underwritten.
Active operating teams in Dubai, Singapore, Tel Aviv, London, Riyadh, Tokyo and New York. Procurement is local; capital is global.
Elmirate Elevate runs the inflection mandate. We have orchestrated multi-jurisdiction listings and complex roll-ups.
Our founders and emerging GP managers tell us the same thing: Elmirate is not absent between board meetings. We are present in market-mapping calls, in regulator introductions, in talent searches, in customer pitches.
Capital is a relationship. We treat it that way.
If you are building a deep-tech company, an emerging frontier-markets fund, or a sovereign-aligned platform — and you are looking for a long-term capital partner who shows up — we should speak.
Capital deployed into defense, biology, quantum and energy carries weight. We do not treat ESG as a marketing exercise; we treat it as engineering. The following framework governs every deployment.
We invest only in companies whose end-use is consistent with the export-control regimes of allied jurisdictions. We do not finance autonomous lethal systems without human-in-the-loop architecture.
Every deployment is measured against a "capability index" — what indigenous capacity is created in the partner nation. Pure financial extraction is incompatible with our mandate.
For biotech and frontier-AI investments we apply elevated diligence — including third-party safety review, dual-use risk assessment, and structured red-team engagements before close.
Portfolio greenhouse-gas intensity is reported to LPs annually. Energy-transition investments are weighted to deliver net-positive system-level emissions outcomes within a 15-year horizon.
Portfolio companies must operate transparent compensation bands, mandatory training programs, and proactive workforce-development partnerships in their host jurisdictions.
Independent directors. Clean cap tables. Quarterly LP reporting against a public-disclosure standard. No off-balance-sheet arrangements.
For founders, fund managers, sovereigns and family offices. We respond to every credible inbound within 48 hours.
Elmirate Capital
Sheikh Zayed Road
Dubai, United Arab Emirates
Mon — Sat · 08:00 – 18:00 GST
Singapore · Tel Aviv · London · Riyadh · New York · Tokyo · Lagos
Operating presence; addresses available on engagement.
The terms governing your access to and use of this website and the materials published on it.
By accessing this website, operated by Elmirate Capital ("Elmirate", "we", "us"), you agree to be bound by these Terms of Use, all applicable laws and regulations, and you accept responsibility for compliance with applicable local laws.
The materials on this website are provided for general informational purposes only. Nothing on this site constitutes an offer to sell, or a solicitation of an offer to purchase, any security, fund interest, or financial product. Any such offer or solicitation will be made only by means of confidential offering documents.
Information published on this site does not constitute, and shall not be construed as, investment, legal, tax, accounting, or other professional advice. Past performance is not indicative of future results. Any forward-looking statements are subject to inherent uncertainties.
Access to certain content may be restricted to qualified investors, institutional counterparties, or other eligible persons under applicable securities laws. By accessing such content you represent that you meet the relevant eligibility criteria.
All content on this website — including text, design, marks, logos, and images — is the property of Elmirate Capital or its licensors and is protected by applicable intellectual-property laws. The Elmirate name and trademark are registered marks. Unauthorized reproduction is prohibited.
This site may contain links to third-party content. Elmirate does not endorse and is not responsible for the content, products, or services of third parties.
To the maximum extent permitted by law, Elmirate, its affiliates, partners, and personnel shall not be liable for any direct, indirect, incidental, consequential, or punitive damages arising out of access to or use of this website.
These Terms are governed by the laws of the United Arab Emirates and applicable Dubai jurisdictions. Any disputes shall be resolved exclusively in those forums.
We may amend these Terms from time to time. Continued use of the site following any amendment constitutes acceptance of the revised Terms.
For questions regarding these Terms, please contact capital@elmirate.ae.
How Elmirate Capital collects, uses, and protects information collected through this website and our engagements.
This Privacy Policy describes how Elmirate Capital ("Elmirate") collects, uses, and discloses personal information from visitors to this website, prospective counterparties, and engagement partners.
We collect information you provide directly — such as name, email address, organisation, and message content submitted through our contact form — and limited technical data such as IP address, browser type and pages visited, collected via standard web analytics.
We use information to respond to inquiries, evaluate prospective engagements, comply with legal obligations including KYC and AML requirements, improve site performance, and communicate periodic updates where consented.
We do not sell personal information. We may share data with service providers under appropriate confidentiality agreements, with regulators where required by law, and with affiliated entities under common control.
As a globally operating firm, your information may be processed in the UAE and other jurisdictions where Elmirate or its providers operate, subject to appropriate safeguards.
We retain personal information only for as long as necessary to fulfill the purposes described, comply with legal obligations, or resolve disputes.
We maintain administrative, technical, and physical safeguards designed to protect personal information against unauthorized access, alteration, disclosure, or destruction. No internet transmission is fully secure.
Subject to applicable law, you may request access to, correction of, or deletion of personal information we hold about you. Contact capital@elmirate.ae.
This site uses essential cookies for functionality and limited analytics cookies for performance measurement. You may disable cookies in your browser settings; some site features may then be unavailable.
We may update this Privacy Policy from time to time. Material changes will be reflected in the "Last updated" date below.